The Rumbaugh-Goodwin Institute for Cancer Research (RGICR) is a non-profit organization located in Plantation, FL, dedicated to developing anti-cancer therapies and investigating the mechanisms of chemotherapy resistance and tumor growth. With a focus on efficient models of cancer growth and metastasis, RGICR aims to bring novel compounds to market quickly and develop targeted therapies with minimal toxicity to patients.
Since its establishment in 1959 and subsequent merger with Nova Southeastern University's Health Professions Division in 2005, RGICR has expanded its programs and research activities. Supported by collaborations with academic and industrial partners, as well as donations and grants, RGICR is committed to advancing cancer research and finding innovative solutions for the treatment of cancer.
Generated from the website